Strategic view: MLB Free Agent Tracker: Top 50 FAs Signings for 2026 Season
Strategic implications in focus: Here are the latest signings from baseball's hot stove as spring training camps continue.
Editorial Staff Mar 8
All Articles
Browse the full archive, newest first.
Strategic view: Serbia: Fears rise over the last independent media outlets
Strategic implications in focus: Concerns grow over potential shifts in media independence following a deal with a state-owned telecommunications company.
Editorial Staff Mar 8
Ibrox Incident Signals Underlying Tensions in Scottish Football Rivalry
The pitch invasion at Ibrox after Celtic's win reveals deeper issues within fan engagement and security in Scottish football.
Editorial Staff Mar 8
Strategic view: Jim Cramer on Howmet Aerospace: “It’s Just in The Sweet Spot”
Strategic implications in focus: Jim Cramer discusses the promising outlook for Howmet Aerospace.
Editorial Staff Mar 8
Strategic view: Jim Cramer on AeroVironment, Inc.: “It’s a Long-time Cramer Fave, But Things Don’t Seem Right Here”
Strategic implications in focus: Jim Cramer expresses concerns about AeroVironment, Inc., despite its long-standing popularity.
Editorial Staff Mar 8
Strategic view: 5 Lessons from Vinay Prasad’s Turbulent Tenure at the FDA
Strategic implications in focus: Vinay Prasad's unique ability to attract criticism — even when his bosses, including the president, wanted him to keep his head low — did him in at the FDA.
Editorial Staff Mar 8
Cancellation of Federal Autism Advisory Board Meeting Signals Operational Challenges
The cancellation of the first public meeting of the federal autism advisory board, post-reconstitution, highlights potential operational inefficiencies and stakeholder engagement risks.
Editorial Staff Mar 7
Strategic view: China Really Thinks It Is Just Defending Itself
Strategic implications in focus: That’s what makes it so dangerous.
Editorial Staff Mar 6
Rivian's 2026 R2 Production Goal: A High-Stakes Move
Rivian's ambition to produce 20,000 R2 units by 2026 positions it against formidable competition, notably the Tesla Model Y, which achieved this milestone faster.
Editorial Staff Mar 6
Strategic view: FDA's Controversial Actions Against UniQure Raise Political Concerns
Strategic implications in focus: Recent FDA decisions could complicate the Trump administration's relationship with drugmaker UniQure.
Editorial Staff Mar 6